A comprehensive longitudinal study spanning more than four decades has provided significant evidence that moderate daily caffeine consumption—specifically two to…
Read More
The Moderate Caffeine Advantage: Long-Term Study Links Daily Coffee Consumption to a Reduced Risk of Dementia and Cognitive Decline
Recent longitudinal research published in JAMA Network Open has provided some of the most compelling evidence to date regarding the…
Read More
JAMA Study Links Moderate Caffeine Intake to Lower Dementia Risk, Providing a Potent Nudge for Adenosine Pathway Drug Hunters
A comprehensive prospective cohort study, published online February 9, 2026, in the prestigious journal JAMA, has unveiled compelling evidence suggesting…
Read More
JAMA study finds moderate caffeine intake tracks with lower dementia risk, provides adenosine-pathway nudge for drug hunters
A landmark prospective cohort study, published online on February 9, 2026, in the esteemed journal JAMA, has unveiled a compelling…
Read More
JAMA Study Uncovers Moderate Caffeine Intake’s Link to Reduced Dementia Risk, Highlighting Adenosine Pathway for Drug Development
A comprehensive prospective cohort study, published online on February 9, 2026, in the esteemed journal JAMA, has revealed a significant…
Read More
Moderate Consumption of Caffeinated Coffee and Tea Associated with Reduced Risk of Dementia and Slower Cognitive Decline Over Four Decades
In a comprehensive longitudinal analysis that spans more than 40 years of clinical observation, researchers from Mass General Brigham, the…
Read MoreYOU MAY HAVE MISSED
